Risk stratification in cardiovascular disease primary prevention - scoring systems, novel markers, and imaging techniques.

Result code in IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00064190%3A_____%2F12%3A%230000464" target="_blank" >RIV/00064190:_____/12:#0000464 - isvavai.cz</a>

Result on the web

<a href="http://dx.doi.org/10.1111/j.1472-8206.2011.01023.x" target="_blank" >http://dx.doi.org/10.1111/j.1472-8206.2011.01023.x</a>

DOI - Digital Object Identifier

<a href="http://dx.doi.org/10.1111/j.1472-8206.2011.01023.x" target="_blank" >10.1111/j.1472-8206.2011.01023.x</a>

Result language

angličtina

Original language name

Risk stratification in cardiovascular disease primary prevention - scoring systems, novel markers, and imaging techniques.

Original language description

The aim of this paper is to review and discuss current methods of risk stratification for cardiovascular disease (CVD) prevention, emerging biomarkers, and imaging techniques, and their relative merits and limitations. This report is based on discussionsthat took place among experts in the area during a special CardioVascular Clinical Trialists workshop organized by the European Society of Cardiology Working Group on Cardiovascular Pharmacology and Drug Therapy in September 2009. Classical risk factorssuch as blood pressure and low-density lipoprotein cholesterol levels remain the cornerstone of risk estimation in primary prevention but their use as a guide to management is limited by several factors: (i) thresholds for drug treatment vary with the available evidence for cost-effectiveness and benefit-to-risk ratios; (ii) assessment may be imprecise; (iii) residual risk may remain, even with effective control of dyslipidemia and hypertension. Novel measures include C-reactive protein

Czech name

—

Czech description

—

Type

J_x - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)

CEP classification

FA - Cardiovascular diseases including cardio-surgery

OECD FORD branch

—

Project

—

Continuities

V - Vyzkumna aktivita podporovana z jinych verejnych zdroju

Publication year

2012

Confidentiality

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Name of the periodical

Fundamental & clinical pharmacology

ISSN

0767-3981

e-ISSN

—

Volume of the periodical

26

Issue of the periodical within the volume

2

Country of publishing house

GB - UNITED KINGDOM

Number of pages

12

Pages from-to

163-174

UT code for WoS article

—

EID of the result in the Scopus database

—